Technology platforms and capabilities
Our pursuit of excellence is underpinned by world-leading capabilities and expertise through our integrated network of Technology Platforms.
RNAte Technology Platform
The RNAte platform is designed to address the need for testing the immunoreactivity of RNA-based products, especially in established human cell models. The platform places a high priority on human induced pluripotent stem cell (iPSC) models for sensitive and accurate detection of immune responses.
Leveraging robotic automation in testing services enables high throughput applications for library screening or testing of different conditions, thereby aiding the optimisation of new product development. Using iPSC models can reduce the risk of clinical trials failure and has the potential to accelerate the development of new RNA and mRNA products in the manufacturing pipeline.
General enquiries | enquiry@rnate.com.au
Hudson Institute Cell Therapies
Accredited Cell Therapy Processing and Cryopreservation Facility in Melbourne
Hudson Institute Cell Therapies (HICT) offers a purpose-built facility for the safe, efficient, and compliant processing and cryopreservation of human blood and tissue products—serving the needs of clinicians, researchers, and industry partners involved in cell and gene therapy. Designed to improve accessibility and streamline clinical workflows, the facility enables the processing of blood products outside the Melbourne CBD, supporting clinical trials both within the Monash Medical Centre Precinct and at other trial sites across Australia.
Operating within a PC2 and ISO 8 certified cleanroom environment, HICT houses a dedicated cryopreservation suite managed under ISO 15189 standards. The facility is accredited to receive, store, and distribute human cellular therapy products, providing essential support for multi-site clinical cell therapy trials and cell therapy services. With a strong focus on quality, safety, and accessibility, Hudson Institute Cell Therapies supports the advancement of cellular therapies through robust infrastructure and close integration with clinical care.
General enquiries | hudson-ct@hudson.org.au
Flow Cytometry
Histology
Genomics
Micro imaging
Proteomics
